FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Top Story

Compugen shares jump on autoimmune drug validation work

Israel's Compugen saw its stock price shoot up 17 percent this morning on the news that it has discovered and completed early validation work on a promising protein that could prove an effective therapy for autoimmune diseases. The developer says that the protein--CGEN-15001--shows promise for multiple sclerosis, lupus erythematosus, Type 1 diabetes and inflammatory bowel disease, along with other ailments. Article

Report

Scientist creates 'nanocage' drug delivery system

Washington University's Younan Xia has been attracting considerable attention for his research work on microcapsules that can precisely deliver a drug payload right where it's needed.Report ⇒

Also Noted

Stem Cell Research

> Harvard Stem Cell Institute researchers say they've managed to make old blood stem cells act young again, a development that could lead to a new approach in slowing the aging process. "What's most exciting is that the changes that occur in blood stem cells during aging are reversible, through signals carried by the blood itself. This means that the blood system offers a potential therapeutic avenue for age-related stem cell dysfunction," says Amy Wagers, an associate professor in Harvard's Department of Stem Cell and Regenerative Biology. Report

Read more >>